Lidocaine Injectable Solution — Competitive Intelligence Brief

Lidocaine Injectable Solution (Lidocaine Injectable Solution) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Anesthesia.

phase 3 Local anesthetic Voltage-gated sodium channels Anesthesia Small molecule

Target snapshot

Lidocaine Injectable Solution (Lidocaine Injectable Solution) — Groupe Hospitalier Diaconesses Croix Saint-Simon. Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses to produce local anesthesia.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Lidocaine Injectable Solution TARGET	Lidocaine Injectable Solution	Groupe Hospitalier Diaconesses Croix Saint-Simon	phase 3	Local anesthetic	Voltage-gated sodium channels
Ropivacaine concentration low	Ropivacaine concentration low	Oslo University Hospital	marketed	Local anesthetic	Voltage-gated sodium channels
Topiramate monotherapy	Topiramate monotherapy	Johnson & Johnson Taiwan Ltd	marketed	Anticonvulsant / Antiepileptic agent	GABA-A receptor; voltage-gated sodium channels
Bupivacaine(B)	Bupivacaine(B)	Huazhong University of Science and Technology	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Bupivacaine supraclavicular block	Bupivacaine supraclavicular block	Jose Soberon, MD	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Bupivacaine low dose	Bupivacaine low dose	Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias	marketed	Local anesthetic	Voltage-gated sodium channels
Anesthetic Topical Adhesive Synera	Anesthetic Topical Adhesive Synera	Brown, Theodore R., M.D., MPH	marketed	Topical local anesthetic	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

1. University of California, San Diego · 3 drugs in this class
2. Durect · 3 drugs in this class
3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
4. Wake Forest University Health Sciences · 3 drugs in this class
5. Medical University of Vienna · 3 drugs in this class
6. Imperial College London · 2 drugs in this class
7. Hvidovre University Hospital · 2 drugs in this class
8. Innocoll · 2 drugs in this class
9. George Washington University · 2 drugs in this class
10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class